Acne in Transmasculine Patients

What is known about the factors associated with acne among transmasculine patients, and where are gaps in knowledge to be addressed in future research?This scoping review of 38 articles found that acne prevalence for transmasculine patients ranged from 29.6% to 61.9%, depending on the methodology. Acne developed 6 to 12 months after initiating testosterone, and younger age was associated with acne while testosterone dosage and route of administration had no association with acne.Younger transmasculine patients may be more likely to develop acne; acne prevalence is high but variable among transmasculine patients, and further research should prioritize the role of testosterone modality and dosage.

Corresponding Author: Olushola L. Akinshemoyin Vaughn, MD, Department of Dermatology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 (akinshemoyin@mcw.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.